Arrow Pressure Injectable Midline Catheter
Midline Catheter. 510(k) K213855, from Arrow International, LLC Subsidiary of Teleflex Incorporated (Morrisville, NC). Product code PND, class 2.
As of Nov 20, 2026, K213855 is an FDA 510(k) held by Arrow International, LLC Subsidiary of Teleflex Incorporated, substantially equivalent on Sep 2, 2022 after 266 days, with 1 recall tied to it in FDA's recall database.
- Review time: 266 days
- Recalls: 1
The Arrow (R) Pressure Injectable Midline Catheter is indicated for short-term (≤ 30 days) peripheral access to the venous system for intravenous therapy, blood sampling, infusion, and pressure injection of contrast media. The maximum pressure of pressure injector equipment used with the Arrow Pressure Injectable Midline Catheter may not exceed 300 psi (2068.4 kPa).
- ARROW Pressure Injectable Midline Catheter with Chlorag+ard Antimicrobial and Antithrombogenic TechnologyK161313 · Arrow International, Inc. (Subsidiary of Teleflex, Inc.) · Aug 24, 2016
| Started | Recall | Status |
|---|---|---|
| Apr 21, 2026 | Z-2387-2026Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if… | Open |
- Midline CatheterK252402 · Terumo Medical Products (Hangzhou) Co., Ltd. · Dec 18, 2025
- Provena(TM) Midline CatheterK213203 · C.R. Bard, Inc. · May 13, 2022
- Stiletto Extended Dwell CatheterK210047 · Piper Access, LLC · Aug 27, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 10, 2021
- Review panel
- General Hospital
- Regulation
- 21 CFR 880.5200
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files